Colgate-Palmolive (NYSE:CL) insider Prabha Parameswaran sold 4,221 shares of the firm’s stock in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $71.68, for a total value of $302,561.28. Following the transaction, the insider now directly owns 16,793 shares in the company, valued at $1,203,722.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Prabha Parameswaran also recently made the following trade(s):

  • On Thursday, August 8th, Prabha Parameswaran sold 55,835 shares of Colgate-Palmolive stock. The shares were sold at an average price of $70.68, for a total value of $3,946,417.80.
  • On Tuesday, August 6th, Prabha Parameswaran sold 5,000 shares of Colgate-Palmolive stock. The shares were sold at an average price of $69.35, for a total value of $346,750.00.

CL traded down $1.58 on Friday, hitting $70.71. The company had a trading volume of 4,669,060 shares, compared to its average volume of 3,494,757. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.13 and a quick ratio of 0.78. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $76.41. The stock has a fifty day simple moving average of $72.68 and a 200-day simple moving average of $70.84. The firm has a market capitalization of $61.88 billion, a P/E ratio of 23.81, a P/E/G ratio of 4.64 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.72 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The business had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.88 billion. During the same period last year, the business posted $0.77 earnings per share. Colgate-Palmolive’s quarterly revenue was down .5% compared to the same quarter last year. Equities research analysts expect that Colgate-Palmolive will post 2.84 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 23rd will be issued a $0.43 dividend. The ex-dividend date is Tuesday, October 22nd. This represents a $1.72 annualized dividend and a yield of 2.43%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.91%.

A number of institutional investors and hedge funds have recently modified their holdings of the business. River & Mercantile Asset Management LLP lifted its holdings in Colgate-Palmolive by 1.0% in the second quarter. River & Mercantile Asset Management LLP now owns 131,752 shares of the company’s stock worth $9,437,000 after buying an additional 1,300 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its holdings in Colgate-Palmolive by 14.0% in the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 369,492 shares of the company’s stock worth $26,481,000 after buying an additional 45,380 shares during the period. Stonehage Fleming Financial Services Holdings Ltd purchased a new stake in Colgate-Palmolive in the second quarter worth about $35,840,000. Rehmann Capital Advisory Group lifted its holdings in Colgate-Palmolive by 11.1% in the second quarter. Rehmann Capital Advisory Group now owns 3,160 shares of the company’s stock worth $227,000 after buying an additional 315 shares during the period. Finally, EP Wealth Advisors LLC purchased a new stake in Colgate-Palmolive in the second quarter worth about $1,198,000. Institutional investors and hedge funds own 76.64% of the company’s stock.

A number of brokerages have recently issued reports on CL. Bank of America set a $80.00 price objective on Colgate-Palmolive and gave the company a “buy” rating in a research note on Friday, July 12th. ValuEngine cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Morgan Stanley raised their target price on Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. UBS Group raised their target price on Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Finally, Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 target price on the stock. in a research note on Friday, June 7th. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and six have assigned a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $73.87.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: Hedge Funds – Risk or Reward?

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.